Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02056249 · ClinicalTrials.gov registry record
Evaluation of the Effect of Hypoglycemia With PET and a Norepinephrine Transporter Ligand
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 9
- Enrollment target
NCT02056249 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 9 participants.
The verdict
NCT02056249 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
Study Summary
The aim of this study is to use Positron Emission Tomography (PET) imaging to measure changes in norepinephrine transporter (NET) concentrations in the brain and periphery of healthy individuals during hypoglycemia. We hypothesize that during hypoglycemia, NE levels will increase within the brain, especially the hypothalamus, and this likely contributes to activation of glucose counterregulatory responses. We further hypothesize that during hypoglycemia, NET concentrations in key glucoregulatory regions will change in order to sustain or prolong sympathetic nervous system activation of counterregulatory responses.
Interventions
- OTHER Norepinephrine Transporter (NET) ligand
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2011-06 |
| Est. Completion | 2017-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02056249
The ClinicalTrials.gov registry entry for NCT02056249 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Norepinephrine Transporter (NET) ligand is the first listed.
NCT02056249 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02056249 about?
NCT02056249 is a clinical study titled "Evaluation of the Effect of Hypoglycemia With PET and a Norepinephrine Transporter Ligand". The aim of this study is to use Positron Emission Tomography (PET) imaging to measure changes in norepinephrine transporter (NET) concentrations in the brain and periphery of healthy individuals during hypoglycemia. We hypothesize that during hypoglycemia, NE levels will increase within the brain, ...
What is the current status of trial NCT02056249?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2011-06. Estimated completion is 2017-06.
What interventions are being tested in trial NCT02056249?
The interventions under investigation include: Norepinephrine Transporter (NET) ligand (OTHER).
Who is sponsoring clinical trial NCT02056249?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.